Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass

NCT02320669 is registered in ClinicalTrials.gov with Seattle Children's Hospital as lead sponsor.

NCT NCT02320669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02320669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Triiodothyronine Supplementation for Infants After Cardiopulmonary Bypass
Lead sponsor
Seattle Children's Hospital
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2014
Completion date
October 31, 2019
Enrollment
220 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart defects